NCT03057028View on ClinicalTrials.gov

Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

June 7, 2018

Study Completion Date

June 7, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Anakinra

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT03057028 - Pilot Study of the Safety and Efficacy of Anakinra in Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter